[go: up one dir, main page]

DE69230314D1 - Cytokinhemmer - Google Patents

Cytokinhemmer

Info

Publication number
DE69230314D1
DE69230314D1 DE69230314T DE69230314T DE69230314D1 DE 69230314 D1 DE69230314 D1 DE 69230314D1 DE 69230314 T DE69230314 T DE 69230314T DE 69230314 T DE69230314 T DE 69230314T DE 69230314 D1 DE69230314 D1 DE 69230314D1
Authority
DE
Germany
Prior art keywords
production
inhibiting
mammal
cytokinhemmer
interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230314T
Other languages
English (en)
Other versions
DE69230314T2 (de
Inventor
Alison Badger
Wanda High
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anormed Inc
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Application granted granted Critical
Publication of DE69230314D1 publication Critical patent/DE69230314D1/de
Publication of DE69230314T2 publication Critical patent/DE69230314T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • AIDS & HIV (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69230314T 1991-02-19 1992-02-18 Cytokinhemmer Expired - Fee Related DE69230314T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65757891A 1991-02-19 1991-02-19
PCT/US1992/001283 WO1992014462A1 (en) 1991-02-19 1992-02-18 Cytokine inhibitors

Publications (2)

Publication Number Publication Date
DE69230314D1 true DE69230314D1 (de) 1999-12-23
DE69230314T2 DE69230314T2 (de) 2000-02-24

Family

ID=24637788

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230314T Expired - Fee Related DE69230314T2 (de) 1991-02-19 1992-02-18 Cytokinhemmer

Country Status (14)

Country Link
US (2) US5602166A (de)
EP (1) EP0572537B1 (de)
JP (1) JP3162071B2 (de)
KR (1) KR930702975A (de)
AT (1) ATE186641T1 (de)
AU (1) AU657745B2 (de)
CA (1) CA2104214C (de)
DE (1) DE69230314T2 (de)
DK (1) DK0572537T3 (de)
ES (1) ES2138595T3 (de)
GR (1) GR3032612T3 (de)
IE (1) IE920508A1 (de)
WO (1) WO1992014462A1 (de)
ZA (1) ZA921120B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201803D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9201804D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
US5594106A (en) * 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
GB9414902D0 (en) * 1994-07-23 1994-09-14 Smithkline Beecham Corp Methods
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
EP0837678A1 (de) * 1995-07-13 1998-04-29 Smithkline Beecham Corporation N,n-dimethyl-8,8-dipropyl-2-azaspiro[4,5] dican-2-propanamin dimaleat
CA2253217A1 (en) * 1996-05-17 1997-11-27 John Gerald Gleason Use of substituted azaspirane in the treatment of asthma
GB2309167A (en) * 1997-05-10 1997-07-23 Anormed Inc The use of azaspiranes in the treatment of Alzheimer's disease
CO5200760A1 (es) * 1999-06-16 2002-09-27 Smithkline Beecham Corp Antagonistas del receptor de la il-8 ceptor il-8
CO5190696A1 (es) * 1999-06-16 2002-08-29 Smithkline Beecham Corp Antagonistas de los receptores il-8
US6184246B1 (en) 1999-07-30 2001-02-06 The United States Of America As Represented By The Secretary Of Agriculture Inhibition of cytokine production by polymethoxylated flavones
WO2002080970A1 (en) * 2001-03-23 2002-10-17 Regents Of The University Of California Method for inhibiting articular cartilage matrix calcification
AU2003220460A1 (en) * 2002-04-05 2003-10-27 Henkel Corporation Curable foam elastomeric compositions
JP2006519842A (ja) * 2003-03-10 2006-08-31 カリスト・ファーマシューティカルズ・インコーポレイテッド アザスピラン化合物による癌治療法
WO2010091381A2 (en) * 2009-02-09 2010-08-12 Callisto Pharmaceuticals, Inc. An intermittent dosing strategy for treating rheumatoid arthrtis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3106552A (en) 1960-07-19 1963-10-08 Geschickter Fund Med Res Nu-substituted azaspiranes and azaspirane-diones and processes for their preparation
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
WO1989011540A1 (en) 1988-05-27 1989-11-30 Synergen, Inc. Interleukin-1 inhibitors

Also Published As

Publication number Publication date
EP0572537B1 (de) 1999-11-17
ATE186641T1 (de) 1999-12-15
IE920508A1 (en) 1992-08-26
CA2104214A1 (en) 1992-08-20
GR3032612T3 (en) 2000-05-31
AU657745B2 (en) 1995-03-23
CA2104214C (en) 2004-04-27
EP0572537A1 (de) 1993-12-08
JP3162071B2 (ja) 2001-04-25
WO1992014462A1 (en) 1992-09-03
DE69230314T2 (de) 2000-02-24
US5602166A (en) 1997-02-11
US5900430A (en) 1999-05-04
JPH06505483A (ja) 1994-06-23
ES2138595T3 (es) 2000-01-16
EP0572537A4 (de) 1993-10-14
ZA921120B (en) 1993-01-27
KR930702975A (ko) 1993-11-29
AU1463392A (en) 1992-09-15
DK0572537T3 (da) 2000-03-27

Similar Documents

Publication Publication Date Title
DE69230314D1 (de) Cytokinhemmer
DK0527879T3 (da) Synergistiske terapeutiske præparater og fremgangsmåder.
IT1177389B (it) Composizioni analgesiche ed anti-infiammatorie migliorate, comprendente xantine e metodi di utilizzare le stesse
FI891690A0 (fi) Foerbaettrad inhalationsapparat foer barnpatienter med astma.
DE68928874D1 (de) Biozide Zusammensetzungen
MY131298A (en) 5-heteroyl indole derivatives
MY104685A (en) Substituted thiazoles and their use as fungicides.
DK0912192T3 (da) Administration af GM-CSF til behandling af hjernetumorer og forebyggelse af sådanne tumorers tilbagevenden
IS4967A (is) Bindill tengdur æxlisdrepthætti
DE69725860D1 (de) PLAN ZUR VERABREICHUNG VON H+, K+-ATPase INHIBITOREN
FI922238A0 (fi) Stoed foer terapeutisk magnet.
IT1236253B (it) Cassetto per mobili.
DE59204265D1 (de) Plattenabspielgerät.
NO890046D0 (no) Disubstituerte pyridiner.
ES2120962T3 (es) Composicion antivirica.
FI935420L (fi) Gasceller i vaetskemedium
ITTO910787A0 (it) Amplificatore di potenza, in particolare di tipo audio
MX9206135A (es) Metodos
DE69217221D1 (de) Hydrochinonderivate und diese enthaltende Antioxydantien sowie Tumorinhibitoren
DE69003908D1 (de) Verstärker mit hohem Wirkungsgrad.
ES1025548Y (es) Sillon para equipo dental.
Christie We Already Have All That We Seek: Prayer as Radical Simplicity
IT1246344B (it) Metodo di dosaggio enzimoimmunologio e corredo di dosaggio relativo.
ITRM910895A1 (it) Dispositivo per elementi scorrevoli da impiegare nel campo dell'arredamento.
IT7924422A0 (it) Procedimento per la realizzazione di candele con elementi decorativi in alto e basso rilievo.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee